Antigenic variation is a strategy used by a broad diversity of microbial pathogens to persist within the mammalian host. Whereas viruses make use of a minimal proofreading capacity combined with large amounts of progeny to use random mutation for variant generation, antigenically variant bacteria have evolved mechanisms which use a stable genome, which aids in protecting the fitness of the progeny. Here, three well-characterized and highly antigenically variant bacterial pathogens are discussed: Anaplasma, Borrelia, and Neisseria. These three pathogens display a variety of mechanisms used to create the structural and antigenic variation needed for immune escape and long-term persistence. Intrahost antigenic variation is the focus; however, the role of these immune escape mechanisms at the population level is also presented.
OVERVIEW
Ross and Thompson's 1910 report of periodic spikes of Trypanosoma gambiense parasitemia (1), made possible by the relatively large size of the parasite, which allowed quantitation using light microscopy, was seminal in understanding how pathogens persist and led to later studies defining how trypanosomes and numerous other pathogens use antigenic variation to evade host immunity and clearance. Antigenic variation is a strategy used by a broad diversity of microbial pathogens to persist within mammalian hosts, from small RNA viruses, notably the human immunodeficiency virus (HIV), to large eukaryotic parasites with multiple chromosomes, illustrated by trypanosomal and malarial parasites (2, 3) . Using a variety of genetic mechanisms to generate antigenic variants, immune evasion results in the infected host serving as a microbial reservoir for subsequent transmission. Unlike respiratory and gastrointestinal pathogens that have essentially continual opportunities for transmission, arthropod vector-borne and sexually transmitted pathogens have episodic transmission opportunities. Correspondingly, both vector-borne and sexually transmitted agents are overrepresented among antigenically variant pathogens (3, 4) .
Pathogens use a breadth of genetic mechanisms to generate antigenic variants (3, 4) . The large progeny size and minimal proofreading capacity allow viruses to use random mutation to generate variants. In contrast, antigenically variant bacteria have evolved mechanisms using a stable genome that safeguards progeny fitness. In this chapter, we focus on three wellcharacterized, highly antigenically variant bacterial pathogens: Anaplasma, Borrelia, and Neisseria. Collectively, these pathogens represent a diversity of bacterial genetic mechanisms used to create variation, structural and antigenic changes required for in-host persistence, and escape phenotypes. While the focus is on intrahost antigenic variation, as opposed to the evolution of new strain variants at the population level, the potential for the same mechanisms used to allow escape from Introduction
In the same year that Ross and Thompson reported the aforementioned observation of recurrent, episodic spikes in trypanosome parasitemia, Arnold Theiler (later Sir Arnold Theiler) published a monograph in which he described the microscopically detectable appearance, disappearance, and then reappearance of organisms "resembling to a certain extent, the bacteria" in the blood of infected cattle (5) . Although 75 years would pass before molecular techniques would define the cyclic waves of bacteremia, Theiler clearly understood that the pathogen, which he termed Anaplasma for its lack of eosinophilic cytoplasm as observed in other tick-borne agents (which at that time were predominantly protozoa), persisted in the host and served as a reservoir for onward transmission (6) . In the past decade the availability of complete genome sequences has driven the discovery of the genetic mechanisms used to generate Anaplasma marginale, and later Anaplasma ovis and Anaplasma phagocytophilum, antigenic variants that escape immune detection and allow persistence. Although the occurrence of outer membrane structural variation resulting in immune evasion is common to numerous bacterial pathogens, study of A. marginale has uncovered two broadly applicable findings that will be the focus here. The first is the mechanism of segmental gene conversion to exponentially expand the capacity of a small, stable bacterial genome to generate thousands of outer membrane protein (OMP) variants. The second is the relevance of gene conversion and its permissiveness for allelic duplication and generation of novel OMP-encoding alleles that permits strain superinfection-essentially immune evasion at the level of the host population rather than within an individual. Strikingly, both these findings also apply broadly to African trypanosomes, highlighting the principle of convergent evolution and unifying the original observations made by Ross and Theiler 75 years ago.
The genus Anaplasma includes A. marginale, the type species, Anaplasma bovis, A. ovis, A. phagocytophilum, and Anaplasma platys (7) . A. marginale and A. phagocytophilum are well-described tick-borne pathogens, while the other three recognized species remain less studied and characterized, although there is evidence that all members of the genus persist in their respective reservoir hosts and are tick-transmitted. A. marginale infects both wild and domestic ruminants, while A. phagocytophilum infects multiple mammalian species (7) . The severity of disease varies by host species and ranges from inapparent infection to severe acute febrile syndromes that progress to severe morbidity and mortality. A. marginale infections in most wild ruminants and Bos indicus breeds are asymptomatic or cause only mild disease. Acute infection of Bos taurus breeds commonly results in severe morbidity and can progress to fatal disease. A. phagocytophilum is also asymptomatic in many reservoir species but is responsible for human granulocytic anaplasmosis, canine and equine granulocytic anaplasmosis, and tick-borne fever in ruminants (7) . Antigenic variation, immune evasion, persistence, and transmission have been most completely studied in A. marginale and are the focus here. However, detailed studies, including complete genome sequencing, of A. phagocytophilum have supported common genetic mechanisms underlying antigenic variation (8) (9) (10) , as have more limited studies for A. ovis and A. platys (11) (12) .
A. marginale Persistence and Transmission
Following initial tick-borne transmission into an immunologically naïve host, A. marginale replicates to >10 8 organisms per ml of blood (reviewed in 13). In surviving animals, the immune response controls this acute-phase bacteremia but results not result in clearance, but rather, in persistence ( Fig. 1 ). Bacteremia levels decrease concomitantly with the detection of IgG antibodies directed against A. marginale OMPs and resolve into a cyclical pattern composed of bacteremic waves ranging between 10 2 and 10 7 organisms/ml (14) . Epidemiologically, persistence provides the reservoir for subsequent tick-borne transmission. As tick populations vary in presence, abundance, and activity seasonally and by macro-and micro-climatic variables, transmission opportunities are episodic rather than continuous. Consequently, persistence in the animal host is required for long-term survival of A. marginale, and achieving persistence is a primary evolutionary force shaping the organism's genome. Importantly, ticks that acquisition-feed on infected hosts during the lower bacteremia levels associated with persistence still successfully acquire A. marginale (15) (16) (17) . Subsequent replication within the tick salivary gland at the time of transmission-feeding to a new host makes up for the initially lower number of organisms ingested, and efficient onward transmission is achieved (17) . 
Cyclic Bacteremia and OMP Variation
A combination of bioinformatics, immunologic, and proteomic approaches has identified ∼60 OMPs in A. marginale (18) (19) (20) (21) (22) . Of these, two closely related proteins, major surface protein (Msp) 2 and Msp3, are both highly abundant and highly immunodominant (12, 22, 23) . The two proteins are similar in structure, with a central surface-exposed region flanked by hydrophobic membrane domains (24, 25) . Msp2 and Msp3 share a common C-terminus and likely were derived from a single ancestral gene. This is supported by the presence of only Msp2 in the closely related A. phagocytophilum but with an allelic repertoire that incorporates the complexity of the A. marginale Msp2/Msp3. In contrast to the other identified OMPs in A. marginale, which are encoded by single-copy genes and are invariant within a strain and during infection of the host, the surfaceexposed domains of Msp2 and Msp3 are encoded by multiple chromosomal alleles, and recombination during infection generates structural and antigenic variants (18, 26) . Studies by French et al. established that the variants expressed in sequential cyclic bacteremic peaks were both structurally and antigenically unique; variants were unrecognized by existing antibody at the time of their emergence and replicated to form a new bacteremic peak ( Fig. 1) (27) . Using quantitative analysis, Brayton et al., confirmed that both Msp2-and Msp3-specific variants emerged in sequential peaks with dramatic loss of the previously predominant variant (28) .
Antibody responses are preferentially directed against the central surface-exposed domains, representing the structurally and antigenically unique regions of Msp2/3 and designated as the hypervariable region (HVR) (29, 30) . Correspondingly, there is minimal antibody recognition of the conserved membrane domains (29, 30) . The variant-specific IgG antibody responses are highly dynamic, with antibody against the HVR being remarkably short-lived compared to the responses against other conserved A. marginale OMPs (30) . This shortlived response was unexpected given the richness of CD4 + T cell epitopes in both variant-specific HVRs and the flanking conserved domains (29, 31) ; the latter would be predicted to provide abundant T cell help for HVR-directed B cell responses due to the principle of linked recognition. However, a series of studies conducted by Wendy Brown and colleagues demonstrated that Msp2-specific CD4 + T cell responses, which can be strongly induced by immunization, were suppressed during A. marginale bacteremia and only restored following antibiotic-mediated clearance of the organism (32) (33) (34) . Although the mechanism of suppression remains incompletely defined, these findings suggest that the ability of Msp2 to evade immune recognition and clearance involves both the structural variation and immunologic modulation.
Genomic Structure and Mechanisms Underlying A. marginale Antigenic Variation
Although Msp2/3 antigenic variation had been identified prior to A. marginale genome sequencing, the completion of the first strain sequenced, the St. Maries strain, fully identified the allelic repertoire responsible for variation and allowed dissection of the mechanisms for long-term persistence (18) . While only a single fulllength Msp2/3 is expressed at one time, using a single operon-linked expression site, multiple alleles encoding unique HVRs are maintained within widely dispersed chromosomal loci ( Fig. 2A ). The nonexpression site alleles are each composed of a variable sequence encoding a unique HVR flanked by highly conserved 5′ and 3′ sequences that are identical to those of the single expression site copy (26) . These alleles lack elements for transcription and translation and are silent in their loci: recombination into the expression site, mediated by the conserved flanking sequences, is required for FIGURE 1 Emergence of Msp2 antigenic variants during cyclic Anaplasma marginale bacteremia. A. marginale replicates to >10 8 organisms per ml during acute infection; the immune response does not completely clear the infection, which persists in a series of sequential bacteremia peaks. Organisms in each peak express an antigenically variant immunodominant surface protein, Msp2, which is not recognized by existing antibody at the time of emergence (as illustrated by the IgG immunoblot for the peak 2 variant). Immune recognition of the variant results in clearance followed by emergence of novel variants in peak 3. Original data from references 14 and 27. expression of the unique HVR. Recombination, which occurs by gene conversion and retains the allelic donor unchanged, results in the expression site encoding a structurally and antigenically unique HVR, replacing the pre-existing Msp2/3 and allowing evasion of immune clearance and replication to form a new bacteremic peak. Detailed tracking of variant progression over time revealed that there is no set order in use of the potential donor alleles; each is capable of being recombined to the expression site and generating a replication-competent Multiple msp2 donor alleles, silent in their chromosomal loci, encode unique hypervariable regions (HVRs), which are expressed only when recombined into the expression site. The allelic repertoire shown is for the St. Maries strain; alleles encoding a unique HVR are shown in different colors; duplicated alleles (2, 3H1; 1, 9H1) are shown in the same color. The expression site msp2 variant, in this example, corresponds to that encoded by the full 9H1 (or 1) allele. (B) Gene conversion generates unique msp2 expression site variants. Sequential rounds of recombination result in replacement of the existing expression site copy by either a whole allelic donor sequence (as shown in the first gene conversion event in which allele 2 is the donor) or progressive modification of the existing expression site copy by segmental gene conversion. Over time, this process of segmental gene conversion generates complex expression site mosaics derived from multiple allelic donors and is reflected in a complexity score. The light blue regions flanking the expression site represent the conserved 5′ and 3′ domains; identical, truncated domains flank each donor allele and direct recombination. A. marginale variant (35) . The position of the locus itself relative to the expression site or origin of replication has no direct effect on variant progression; rather, the encoded HVR itself is deterministic, consistent with the importance of immune escape (36) .
Notably, the A. marginale genome contains approximately 10 to 12 total unique msp2 and msp3 donor alleles (18, 37) , too few to account for the number of bacteremic peaks observed and required for years of persistence. This paradox was resolved by a series of detailed studies that identified segmental gene conversion as a combinatorial mechanism to exponentially expand the potential repertoire ( Fig. 2B) (35, 38, 39) . Recombination of an oligonucleotide segment derived from the donor allele hvr into the existing expression site hvr generates a novel, mosaic expression site msp2 not previously represented anywhere in the genome. Two further keys to understanding this mechanism were definition of how recombination was guided and how a mosaic could maintain minimal Msp2 structure. Futse et al. demonstrated an anchoring mechanism in which only either the 5′ or the 3′ conserved flanking sequence was required for recombination of a segment (35) . The lack of a requirement for internal sequence identity allows tremendous expansion in the number of possible variants-assuming these would maintain a protein structure required for at least minimal fitness. Examination of several hundred mosaic HVRs identified stretches of 2 to 10 highly conserved amino acids, including conserved cysteines, which serve as structural "tethers" to maintain overall Msp2 structure (40) . Thus, the HVR is itself composed of hypervariable microdomains that provide the diversity underlying antigenic variation with overall Msp2 structure maintained by the conserved tether elements. The resulting combinatorial diversity in the variant repertoire is estimated at 4 5 variants (four microdomains generated by segmental gene conversion using a minimum of five unique alleles per genome), consistent with continual antigenic variation.
Competing Selective Pressures for Immune Escape and Variant Fitness
Unlike the Msp2 variants generated from recombination of the intact hvr encoded by a donor allele, mosaic variants generated by segmental gene conversion exist only in the expression site and only transiently-due to the unidirectional recombination which results in the loss of the expression site copy. As a consequence, mosaic variants are under long-term selection not for maximal structural fitness but only for short-term ability to evade immune recognition and clearance. In the absence of an adaptive immune response in the host, variants generated by recombination of the intact hvr from the chromosomal alleles (designated "simple variants") have a competitive advantage over mosaics generated by segmental gene conversion ("complex variants"). This is supported by two lines of evidence-both of which have relevance for pathogenesis and epidemiology. The first is that acute bacteremia in a newly infected host is composed of simple variants; over time as the repertoire of simple variants is expressed and sequentially cleared, mosaics generated by segmental gene conversion appear and predominate (35) . As the infection continues to persist, variants become increasingly complex, with mosaics assembled with oligonucleotide segments derived from multiple alleles (Fig. 3A ). This selection for complex variants occurs only under selective pressure of the adaptive immune response; direct inoculation into an immunologically naïve host results in acute bacteremia, again composed of simple variants ( Fig. 3B) (41) . The highlevel bacteremia in acute infection reflects, at least in part, the core fitness of simple variants with a 10 2 to 10 3 reduction in fitness as complex variants emerge. The second supporting observation is that upon natural acquisition-feeding by ixodid ticks on a persistently infected host, ingested complex variants are rapidly lost from the A. marginale organism, and simple variants predominate in the tick midgut and, importantly, in the salivary gland upon onward transmission-feeding ( Fig. 3C ,D) (41) (42) (43) . These findings underlie the paradox whereby a persistently infected host cannot clear its existing infection-due to sequential assembly of new mosaic variants by segmental gene conversion-but is immune to a new infection with the same strain, which expresses simple variants previously encountered. Importantly, this provides the framework for understanding antigenic variation at the level of the host population and how population immunity drives divergence in strain structure.
Population Immunity as a Driver of Strain Superinfection
Strain superinfection occurs when a second, genetically distinct pathogen strain infects a host that has already been infected with and mounted an immune response to a primary strain. Perhaps best understood in viruses, as illuminated by studies of HIV and hepatitis C virus (44, 45) , the principles can be more broadly applied to more complex pathogens, including bacteria and protozoa. Following initial identification of A. marginale strain superinfection under conditions of natural transmission (47) , and Futse et al. demonstrated that even a single unique allele was sufficient to allow a second strain to superinfect and that strain superinfection required sole expression of the unique allele as an antigenically distinct Msp2 (48) . This was in marked contrast to nonsuperinfecting strains that shared only identical alleles.
The complete msp2 allelic repertoire was determined for multiple strains using a combination of targeted and whole-genome sequencing (48) . Unlike the overall A. marginale genome, which is considered to be "closed core" with a high level of conservation in gene content and within individual genes (47) , alleles encoding Msp2/ 3 differed as much between superinfecting strain pairs as they did within a strain (48)-the latter being the basis for continual antigenic variation within an individual infected host. This led to the hypothesis that immunity at the population level was selecting for strain divergence, specifically in the variant-encoding alleles, with the capacity to evade pre-existing immunity raised by a primary, existing strain. Three lines of evidence have supported this hypothesis. The first is that strain-specific variation in the primary structure of encoded simple FIGURE 3 (continued) variants is reflected in the lack of immune recognitionallowing evasion of immunity raised by the primary strain. Successful transmission of the secondary strain, which expresses simple variants in the tick vector, requires that one of the simple variants be sufficiently different to allow initial replication without immune recognition (48) . Second, once established, superinfecting strains continue to generate, via segmental gene conversion, complex variants that reflect the greater level of overall antigenic diversity compared to singlestrain primary infection (40) . Third, the incidence of superinfection increases with the overall prevalence of A. marginale infection (40, 49) . At low levels of infection prevalence and consequent population immunity, there is a large proportion of immunologically naïve hosts and therefore minimal selective pressure for divergence. However, as infection prevalence rises-especially toward saturation, as occurs in the tropics-the selective pressure markedly increases (40, 49) . A "newly emergent" strain, defined as having at least one unique allele, whether derived de novo or exogenously introduced, has a clear selective advantage because the host population is immunologically naïve to the new strain ( Fig. 4 ).
This duality of A. marginale antigenic variation for persistence both within the individual host and at the level of the host population role of interaction is consistent with propagation of self. Not surprisingly, this duality has also been recently observed in other highly antigenically variable bacterial pathogens, including but not limited to Borrelia burgdorferi (50), which is discussed in a subsequent section of this chapter.
Knowledge Gaps
Several significant knowledge gaps remain regarding mechanisms and selection determinants of A. marginale strain structure. How a new strain evolves from an existing one is not understood; both the rate of allelic change and mechanism(s) of change are unknown. One clue comes from the presence of exactly duplicated alleles in different loci within a strain (18, 37) . This suggests that the duplicate allele could serve as a template for change, essentially experimentation to result in a sufficiently diverse allele to allow superinfection, without jeopardizing the existing complement of alleles that allow antigenic variation within the individual host. This is supported by identification of two unique alleles in a second strain that are in the identical loci occupied by duplicated alleles in the first strain (37) . The mechanism by which a new sequence is introduced is also currently uncertain. Although 99% of variants map completely to one or more donor alleles, novel expression site variants characterized by mutation, insertions, and deletions at sites of segmental recombination have been identified (35) . Gene conversion in reverse, resulting in an expression site sequence replacing a pre-existing allelic hvr, could generate de novo allelic change with "successful" alleles being retained in the genome.
Finally, the trade-off between variant diversity that allows strain superinfection and maintaining minimal structure for bacterial fitness represents a clear knowledge gap with major epidemiological implications. Unchecked pressure only for allelic divergence would be expected to result in strain "chaos"-with dozens or more unique strains within a defined host population. However, study of naturally occurring infections identifies a much more limited strain structure, often defined by a predominant strain (40, 46, (51) (52) (53) . The current hypothesis is that there is a dynamic balance between allelic divergence to allow superinfection and retention of minimal protein structure for bacterial fitness (54) . Only under conditions of high population immunity do the lower fitness strains compete successfully and only within the structural limits of maintaining minimal function ( Fig. 4 ). Addition of new hosts, by birth or exogenous introduction, favors the most fit strain, maintaining its predominance. Testing of this hypothesis under conditions of natural transmission is proposed as a needed and potentially illuminating set of experiments with broad relevance.
BORRELIA Introduction
The genus Borrelia represents a genetically unique and highly separated lineage within the Spirochaetes branch of the bacterial kingdom (55, 56) . These pathogenic spirochetes are obligated to a life cycle that requires transmission by hematophagous arthropods and longterm maintenance within a vertebrate host. All members of the Borrelia genus are defined by an unusual genome that consists of a linear chromosome and multiple linear plasmids containing covalently closed hairpin ends. Borrelia hermsii and B. burgdorferi are two well-studied members that exemplify relapsing fever and Lyme disease agents, respectively (55, 57, 58) . A number of Borrelia species have been implicated in causing either the epidemic or endemic form of relapsing fever (56) . Borrelia recurrentis is the only representative species responsible for causing epidemic relapsing fever, which is transmitted by the human body louse, Pediculus humanus. The remaining species are agents of the endemic form of relapsing fever and are primarily transmitted by soft-bodied ticks of the genus Ornithodoros. Both forms of the disease are characterized by recurrent spikes of high fever that correlate with periods of bacteremia that can reach levels as high as 10 8 spirochetes per milliliter of blood (59) . Each febrile episode corresponds to spirochetes that produce a different form of the Vlp or Vsp lipoprotein through an antigenic variation system that is crucial to the success of relapsing fever borreliae as pathogens (60, 61 ). An effective host humoral response against Vlp/Vsp reduces the bacterial load in the blood, which brings about the resolution of fever in the host (62, 63) . New vlp/vsp variants arise in the host at a frequency of 10 -3 to 10 -4 per cell per generation (59) and in turn proliferate and seed the next wave of spirochetemia.
The multisystem disease known as Lyme disease (or Lyme borreliosis) is the most prevalent vector-borne infection affecting humans in both North America and Europe (64, 65) . B. burgdorferi, Borrelia garinii, and Borrelia afzelii are the causative bacterial agents of the disease and are transmitted by hard-bodied ticks of the genus Ixodes. Infected ticks transmit Lyme disease FIGURE 4 Anaplasma marginale strain superinfection is favored under the selective pressure of high population immunity. Circles indicate the existing animal population at T o : white represents uninfected and immunologically naïve hosts; blue represents hosts carrying strain A; orange represents strain B; and purple represents hosts superinfected with strains A and B. Squares represent individual hosts introduced to the population by birth or immigration. The intrinsic transmission fitness is greater for strain A than strain B (TE A ≫ TE B ). Under conditions of low prevalence of infection (and hence low population immunity), strain A predominates. Following introduction of strain B, its transmission is at a strong disadvantage and there is minimal selective pressure for strain B superinfection. Consequently, strain A predominance is maintained over time. Under conditions of high prevalence of infection (and high population immunity), strain A is predominant, but there is strong selective pressure for strain B superinfection. Strain A transmission is favored for newly introduced naïve hosts and thus remains predominant but accompanied by prevalent superinfection. Figure and legend from reference 54 with permission.
borreliae to humans during feeding, which can result in a localized infection (erythema migrans) at the site of the tick bite. Disseminated and chronic stages of infection follow; these are characterized by neurological, cardiological, and arthritic manifestations of disease. Infection with Lyme disease borreliae can last from months to years due to avoidance of the host immune response, and key to its successful evasion tactics is recombination at the vls locus located at the telomeric end of a 28-kilobase linear plasmid (4, 66, 67) . Gene conversion events within the vls locus result in sequence variations of the VlsE surface lipoprotein that in turn alter its antigenic properties and provide the spirochete with the ability to evade the host's antibody-mediated response (67) (68) (69) . Although similarities and differences exist between the antigenic variation systems of relapsing fever and Lyme disease borreliae, this chapter will focus on the more well-studied vls system of the Lyme disease spirochete.
A schematic of the vls locus from the B. burgdorferi B31 strain is shown in Fig. 5 . The locus consists of the vlsE expression site that encodes the 35-kDa lipoprotein, which is located 82 base pairs (bp) from the right telomere end of the linear plasmid, lp28-1 (66) (67) (68) . The locus also includes a tandem array of 15 silent cassettes (vls2-16; each approximately 500 bp in length) that are oriented in the opposite direction of the vlsE gene. A short intergenic region (∼160 bp) separates the vlsE locus and the silent cassettes, and this intergenic space contains a near-perfect inverted repeat of a 51-bp sequence capable of forming a highly stable DNA stem loop (70) . In addition, a portion of the promoter sequence required for vlsE expression is located within this inverted repeat (70) . The vlsE expression region is comprised of a central variable cassette ( Fig. 5 , blue region) that is flanked by constant regions (yellow). At the junction of the variable and constant regions are 17-bp direct repeats. With the exception of the final cassette, 17-bp direct repeat sequences are also found at either end of the silent cassettes. The vlsE cassette region exhibits roughly 90% sequence identity with each of the silent cassettes (67) , and most of the sequence differences reside in six variable regions ( Fig. 5 , light blue) that are flanked by six highly conserved, or invariant, sequences (dark blue).
The vls Locus in Immune Evasion and Persistence
A number of experimental findings over the years have provided strong evidence implicating the importance of VlsE antigenic variation for B. burgdorferi persistence. The first studies involved determining the kinetics of gene conversion, and recombination events were observed as early as four days after infection of mice and continued to occur throughout infection (69) . However, assessing the exact rate of variation has proven difficult; this is because vlsE antigenic switching only occurs during mammalian infections (71) , and B. burgdorferi is not readily sampled from the blood. VlsE variation occurs to such a degree that each clone examined from a single mouse skin biopsy can have a different vlsE sequence after only 28 days postinfection, and the sequence changes primarily occur within the six variable regions. Early work also demonstrated that antibodies specific for the variable regions of VlsE were produced during experimental infection of mice (72) .
More evidence for the role of the vls system in immune evasion came from studies involving the vlsresident plasmid, lp28-1 (73, 74) . Clones lacking lp28-1 were shown to exhibit an infectivity phenotype whereby these spirochetes were able to disseminate to tissue sites but were unable to persist in the murine host. Notably, these same clones are capable of long-term survival in severe-combined immunodeficient (SCID) mice that lack an effective antibody response (75, 76) . Lp28-1-deficient isolates also grow normally in a dialysis membrane chamber implanted in the peritoneal cavity of rats, where exposure to either antibodies or immune cells is restricted (76) . Finally, immunocompetent mice infected with an lp28-1 minus strain complemented with only the vlsE gene (sans the vls silent cassettes) are able to clear infection, demonstrating that it is not the mere presence of VlsE that provides the capacity for persistent infection, but rather the ability to undergo vls antigenic variation to produce VlsE variants (77) . Although these studies provided a strong indication that lp28-1, and presumably the vls locus, are required for persistence only in the presence of an effective humoral immune response, definitive evidence for the role of VlsE antigenic variation in immune evasion remained elusive until the generation of a genetic deletion of the vls locus.
The construction of a vls knockout mutant in B. burgdorferi was made possible by taking advantage of the linear nature of lp28-1 (Fig. 6A ). The method used involves integration of a plasmid containing a replicated telomere within a chosen linear plasmid of B. burgdorferi (78) (79) (80) . The end result of the internal placement of the replicated telomere is deletion of DNA through the action of the Borrelia telomere resolvase, ResT (80, 81) . Spirochetes that lost the vls locus due to telomere-mediated removal were completely cleared from immunocompetent C3H mice by day 21 postinfection (78) , matching the phenotype observed with clones that lacked the lp28-1 plasmid. Consistent with the findings that lp28-1 is not required for persistent infection in the absence of an adaptive immune response (75) (76) (77) , the vls deletion mutant exhibited long-term survival in SCID mice, thereby confirming the hypothesis that vls recombination functions to evade the humoral immune response in the mouse host (66, 67) .
Targeted deletion was also utilized to obtain lp28-1 mutants containing mainly the vls locus and the necessary genes for autonomous replication of the plasmid (Fig. 6B ). The only other potential genes retained on the lp28-1 mutant plasmid were eight very small open reading frames (bbf19 to bbf22 and bbf27 to bbf30) predicted to potentially encode for proteins consisting of only 82 amino acids or less. Infectivity experiments showed that these B. burgdorferi clones are fully infectious and persistent in immunocompetent mice, providing further evidence that the silent vls cassettes and vlsE are involved in spirochete persistence (78) . Moreover, these mutant clones carried out vlsE recombination in immunocompetent C3H mice, indicating that protein factors required for antigenic switching are likely not carried on lp28-1 but encoded elsewhere.
The remaining presence of the small ORF regions bbf19 to bbf22 and bbf27 to bbf30 left open the possibility that the loss of genes within these loci could have some role in the intermediate infectivity phenotype exhibited by the lp28-1-deficient clones and was not due solely to an absence of the vls locus. A study published by Embers et al. reported that expression of the immunodominant outer surface protein C (OspC) by an lp28-1-deficient B. burgdorferi clone was abnormally high in vivo, suggesting that downregulation of this protein is impaired (82) . Previous studies have shown that OspC is downregulated in B. burgdorferi shortly after establishing infection in the animal host, and it has been suggested that this provides the spirochete with a mechanism to avoid clearance mediated by anti-OspC antibodies (83) (84) (85) . The overall conclusion from the Embers et al. study was that failure of OspC repression by lp28-1-deficient spirochetes renders them susceptible to immune-mediated clearance, which could potentially be responsible in part for the intermediate infectivity phenotype associated with these B. burgdorferi clones. Thus, the possibility was raised that one or more genes involved in ospC repression may be present on the lp28-1 plasmid. However, recently generated mutants lacking either region bbf19 to bbf22 or bbf27 to bbf30 were found to be capable of persistent infection of immunocompetent C3H mice for up to 91 days (Hove and Bankhead, unpublished data). Together with previously published results involving additional lp28-1 deletion mutants, this raises the likelihood that the vls locus is the only lp28-1-resident genetic system responsible for persistence during infection of the mammalian host.
Mechanism of Recombination
Although gene conversion has been implicated in vlsE antigenic variation, little is known about the exact mechanism of recombination and the proteins involved in this process. Since the discovery of the vls system almost two decades ago, progress toward elucidating the mechanistic details of recombinational switching has been impeded by two factors. First, switching does not occur in either culture or the tick vector, but instead requires passage through a mammalian host (66) , and second, the vls locus is genetically unstable when cloned in E. coli (67, 86) . The proposed model for vlsE antigenic switching involves a nonreciprocal gene conversion mechanism whereby segments within the vlsE central cassette region are replaced by sections of varied length and location from the silent cassettes ( Fig. 7) . Only the cassette region of vlsE displays sequence variation resulting from gene conversion; the sequence and organization of the silent cassettes remain unaltered (69) . An elaborate study by Norris and colleagues examined 1,399 clones isolated from various tissue sites of mice infected from 4 to 365 days (87) . Detailed analysis of the vlsE sequence changes found that the vls antigenic variation system promotes both short and long recombination events within each cassette region. Along with the gene conversion events, FIGURE 6 Telomere-mediated deletion of the vls locus in Borrelia burgdorferi. (A) Construction strategy for the generation of the vls deletion mutant clone of B. burgdorferi B31. The target sequence for insertion (green) is chosen so that only the vls locus would be deleted from the lp28-1 plasmid. The genes encoding plasmid maintenance proteins that have been previously shown to allow autonomous replication are shown as black arrows. (B) Schematic of the construction strategy for the lp28-1Δleft plasmid. The target sequence for insertion (green) was chosen so that only the genes encoding proteins that allow autonomous replication of lp28-1 (shown as arrows arranged from left to right) and the right side of lp28-1 would remain. Hairpin telomeres are shown as red hatched regions. Figure adapted template-independent changes also occur that lead to additional sequence variation of vlsE. The end result of these accumulated changes is a new vlsE sequence with a mosaic structure, and the total combined potential for sequence variation makes the vlsE switching process one of the most dynamic antigenic variation systems known.
Surprisingly, the RecA protein does not seem to be required for the generation of VlsE antigenic variants, despite being involved in DNA repair and homologous recombination in the spirochete (88) . This is in sharp contrast to other well-studied antigenic variation systems that are RecA-dependent, such as the pilE locus of Neisseria gonorrhoeae (89) . Similarly, disruption of a large number of genes involved in DNA recombination, repair, and replication ruled out the involvement of their respective encoded proteins in vlsE switching (90, 91) . However, these same studies did find that the RuvAB complex of B. burgdorferi is required for vls antigenic variation, presumably by promoting branch migration of Holliday junctions during vlsE recombination (90, 91) . Interestingly, while B. burgdorferi contains genes that encode the branch-migration complex RuvAB, these spirochetes are noticeably lacking the gene for the Holliday junction resolvase, RuvC. In fact, no recognizable ortholog exists in the B. burgdorferi genomic sequence, which suggests that a specialized Holliday junction resolvase may be expressed in the spirochete. This raises the question of how the Lyme disease pathogen promotes recombination at the vls locus with such a limited involvement of the usual collection of DNA recombination proteins.
One possible answer is that the vlsE antigenic switching process may involve the formation of G-quadruplex DNA structures. A study by Walia and Chaconas found that guanine quartet (G4) DNA could be formed by G-runs located in the 17-bp direct repeats of the vlsE gene (92) . A G-quadruplex DNA structure has been shown to have a role in pilin antigenic variation in N. gonorrhoeae by acting as a signal for DNA strand nicking (93, 94). However, this process involves recombination proteins that are either known not to exist in B. burgdorferi or have been shown not to have a role in antigenic switching. Moreover, the G-runs found in the vls locus are not separated by short stretches of DNA similar to that typically found with G4 DNA. Thus, it remains unclear whether G-quadruplex formation has an actual role in vlsE recombination or if intermolecular interactions between the G-runs of the direct repeats promote gene conversion through an entirely different mechanism.
The VlsE Lipoprotein
The crystal structure of the recombinant-variant VlsE outer surface lipoprotein presents a three-dimensional protein fold that is substantially different from most other solved protein structures (95) . Despite this unique configuration, analysis of the VlsE protein structure did reveal a resemblance to the variable surface protein of the relapsing fever agent, B. hermsii. The VlsE monomer is also quite similar to the overall protein fold of the OspC dimer structure, with both presenting membrane distal alpha-helical bundles to the host environment (95, 96) . The overall primary structure of VlsE consists of N-terminal and C-terminal constant domains that flank the central cassette region. The loops containing the variable regions are localized at the distal surface of the protein, while the C terminus is positioned close to the N terminus that is attached to the bacterial lipid outer membrane. Gel filtration chromatography of VlsE showed that that the protein is primarily monomeric in solution, although the observed interface in the crystal structure raises the possibility that VlsE could exist as a dimer on the bacterial cell surface.
The observed position of the variable regions at the distal surface of VlsE confirms their accessibility to FIGURE 7 Overview of vlsE antigenic switching in Borrelia burgdorferi. Variant-specific segments act as a source of DNA for nonreciprocal recombination events with the vlsE expression locus. Through this process, segments of the variable region (blue) are replaced by sections of varied length and location from the donor sequences. In the example shown, three sequential gene conversion events (represented by dashed lines) occur within each expression site through recombination with the colored donor sections (yellow, green, or red) to generate a new expression site sequence with a mosaic structure. Figure adapted from reference 4 with permission.
antibodies. In contrast to the variant regions, the invariant regions of VlsE have very limited surface exposure. Despite the apparent inaccessibility to antibodies, a strong humoral response is mounted against the conserved regions of VlsE (most notably invariant region 6). In fact, VlsE-based recombinant proteins or synthetic peptides are used for the immunodiagnosis of Lyme disease (97) (98) (99) (100) (101) . The function of VlsE independent of its antigenic variation properties is not currently known. There have been previous indications that VlsE may be involved in tissue tropism, including reports that VlsE production is elevated during mammalian infection (102) , with higher levels observed in spirochetes recovered from joint and skin tissues than from heart tissue (103) . However, a recent study found no obvious differences in the amino acid sequence of VlsE variants recovered from different tissue sites, suggesting the absence of any VlsE role in tissue tropism (87) .
Knowledge Gaps
Past research involving B. burgdorferi antigenic variation has focused on either analyzing vlsE sequence changes, the dynamics of those changes, or the role of vlsE switching in B. burgdorferi pathogenesis. However, studies that address the fundamental question of how antigenic variation occurs in B. burgdorferi have been seriously lacking. In addition, the use of molecular approaches to study vls recombination has been limited. Despite the widespread nature of this effective pathogenic strategy, few molecular details of the recombinational switching process have been reported for any organism.
A number of aspects regarding the molecular details of VlsE antigenic variation remain unknown and will likely be the focus of future experimental studies. For example, the subtelomeric positioning of the vls locus is a common feature associated with many antigenic variation systems found in both eubacterial and protozoal pathogens (104, 105) . The reasons behind this phenomenon are still unclear and could potentially be of great significance to the overall mechanism of antigenic variation. The importance of the 17-bp direct repeats that demarcate the vlsE variable region and flank the silent cassettes is also currently unknown. Although it was originally thought that these sequences might play a role in recombinational switching (67), sequence analysis showed that these repeats are not well conserved across Borrelia species and even within some species, casting doubt on a proposed role in recombination (106) . However, the recent finding that G4 DNA can be formed at the guanine-rich 17-bp direct repeats may warrant further investigation into the potential mechanistic importance of these sequences for vls gene conversion. Nevertheless, any potential roles of these direct repeat elements for vlsE recombination during host infection have not been directly investigated. Also remaining to be determined is whether the vlsE-silent cassette intergenic region is required for vls antigenic variation. One intriguing idea is that the stem loopforming potential of the intergenic region between vlsE and the silent cassette array delivers the cassette copies to vlsE during the gene conversion process. Finally, a study demonstrated that antigenic switching does not occur with a trans copy of vlsE during infection, suggesting a possible cis requirement for the vls recombination mechanism (77). However, the trans copy of vlsE was carried on a circular shuttle vector, as opposed to the linear lp28-1 plasmid in which vlsE normally resides, and whether this may have inhibited recombination between the shuttle plasmid and lp28-1 will require additional studies.
A role for the VlsE protein other than providing an antigenic disguise is not currently known, but it has been proposed that the protein might function in other forms of immune evasion (107, 108 ). An elegant study by Tilly, Bestor, and Rosa demonstrated that VlsE and OspC may share similar but distinct roles during host infection (109) . Unfortunately, the exact function(s) of the OspC protein also remains undefined, and thus exactly what common role these two lipoproteins may share is still a mystery. Based on previous studies, it has been speculated that they may protect the pathogen from host defenses. Alternatively, they may aid in stabilizing the bacterial structure during host infection similar to the role recently demonstrated for OspA and OspB in lipid rafts on the spirochete membrane (110, 111) . Though OspC was not found to be associated with these lipid rafts (111) , high levels of either OspC or VlsE may still function in some fashion as an essential component for overall stability of the bacterial outer membrane.
Although a number of other surface proteins exist that are immunogenic, VlsE is the only known B. burgdorferi antigen that exhibits variation of its surface epitope. A daunting question regarding B. burgdorferi immune escape has been how such a feat is accomplished through sequence variation of this single lipoprotein, despite the presence of a substantial number of additional antigens residing on the bacterial surface. Many pathogens use their antigenically variable proteins in a number of ways as an evasion strategy, and several models have been suggested for how VlsE might become the primary target for the host immune response. In other pathogen systems, such as that found in Trypanosoma brucei, the variable surface protein hides other antigens by essentially coating the surface of the organism (112, 113) .
It is possible that VlsE may act as a shield to obscure the epitopes of other surface antigens. In fact, crystallography data suggests that the binding of VlsE to other proteins on the membrane surface may block antibody binding to the lateral surface of VlsE (95) . This in turn may protect other surface antigens that are tightly juxtaposed to VlsE from antibody recognition (Fig. 8A) . A precedent for this type of interaction has been demonstrated in studies with the Borrelia protein P66, in which the protein is protected from proteolytic cleavage in Lyme Borrelia expressing high levels of the outer surface protein OspA (114) .
With respect to VlsE-mediated shielding, experiments using either in vitro-grown or host-adapted wild-type B. burgdorferi were conducted to determine whether VlsE expression could provide Lyme disease spirochetes with the capacity to reinfect mice (115) . The levels of VlsE expression have been shown to be upregulated 32-fold during host infection relative to those measured in vitro (102) . Unlike the highly susceptible in vitrogrown spirochetes, B. burgdorferi that have adapted within the animal host have been demonstrated to be relatively invulnerable to the protective effects of immune sera (116, 117) . The study showed that cultured (low VlsE-expressing) wild-type B. burgdorferi are unable to reinfect mice, while host-adapted (high VlsEexpressing) wild-type spirochetes are fully competent for host reinfection (115) . Additional experiments involving wild-type and VlsE mutant clones found that only the wild type could reinfect mice initially infected and cleared of spirochetes devoid of VlsE. In other words, the immune response of these mice was sufficient to prevent reinfection by a VlsE-deficient clone but could not block reinfection by spirochetes capable of expressing variable VlsE (see Fig. 8B ). It was also shown that SCID mice treated with immune sera generated to a VlsE-deficient mutant were resistant to infection by this same clone but could be successfully challenged by host-adapted wildtype B31 spirochetes expressing VlsE (115) . The finding that passively transferred antibodies developed to non-VlsE surface antigens can provide immunity against the VlsE-deficient clone but were not borreliacidal to wildtype spirochetes, may hint at a possible VlsE-mediated shielding mechanism. Finally, VlsE expression is known to be highly reduced while in the tick environment, and in agreement with findings described above, mice fed with wild-type-infected ticks are immune to reinfection (Rogovskyy and Bankhead, unpublished report). Together, these data indicate that the adaptation state of infecting spirochetes, likely due to its respective effects on VlsE expression, can greatly influence B. burgdorferi evasion from the host antibody-mediated response (see Fig. 8C ). Determining whether this VlsE-mediated immune avoidance system involves epitope shielding will require further investigation.
It has also been proposed that VlsE might be a T-cellindependent antigen that could directly stimulate certain B cell subsets (78, 108) . The resulting humoral response generated by VlsE may override antibody production against other potential surface antigens. It has been observed that vls mutant B. burgdorferi clones complemented with a nonswitchable form of vlsE are cleared faster in immunocompetent mice relative to non VlsEcomplemented mutants (78) . It is conceivable that this outcome could be the result of direct stimulation of B cells by VlsE, and this modulating ability could result in more effective clearance of these spirochetes due to the absence of VlsE antigenic variation in those clones. In support of this, a recent study found that sera derived from nude mice infected with wild-type B. burgdorferi contained anti-VlsE T-cell independent antibodies at sufficient levels to prevent infection by in vitro-grown wild-type B. burgdorferi but were at inadequate quantities to prevent infection by the VlsE-deficient mutant clone. This finding is suggestive that the T-cell independent antibody response is directed primarily to VlsE, with subdominant titers of these antibodies against non-VlsE surface antigens as demonstrated by their inability to prevent infection by the VlsE-deficient mutant clone.
Finally, because survival of the Lyme pathogen in nature is completely dependent on its enzootic life cycle, it would be interesting to assess whether the variantgenerating capacity of the vls system is required for the Lyme pathogen to be efficiently and successfully perpetuated throughout its life cycle. Although never tested, the expected outcome would be that antigenic variation of VlsE is required for persistence in the natural reservoir host. Also unknown, and potentially more interesting, are the effects of vls mutation on the ability of B. burgdorferi to be acquired, persist, and be transmitted to naïve mice by Ixodes ticks. In all, continued efforts toward identifying the mechanism responsible for B. burgdorferi immune escape has important implications in the development of vaccines against the pathogen and other Borrelia species. If the protective effects of VlsE can be minimized using therapeutics, then an effective vaccine can be developed and used in conjunction to prevent infection or reinfection by the Lyme disease spirochete. Additionally, such knowledge could lead to the development of novel strategies for targeting Lyme disease Borrelia in the tick vector and/or reservoir host. Overall, such future studies will significantly advance our knowledge of immune evasion by B. burgdorferi and could in turn have broad implications for other animal and human pathogens.
NEISSERIA Introduction
The genus Neisseria contains groups of Gram-negative, proteobacterial species, most of which colonize mucosal surfaces of mammals but are commensal organisms that do not normally elicit pathology or cause disease (118) . Whether they have a mutualistic relationship with their hosts has not been established, but considering their long coevolution with their host, it is likely. There are 11 species that colonize humans, and these species appear to be host-restricted since they are not known to inhabit any other natural ecological niche. It is unknown whether a progenitor of the human-restricted Neisseria colonized a human and the 11 species evolved from this one progenitor or whether a progenitor colonized one or more different hosts and then transferred and adapted to life exclusively within humans. While all of these organisms have the ability to colonize mucosal surfaces and grow, only two members of the genus are considered to be frank pathogens with serious sequelae of morbidity and mortality (118) . The pathogenic Neisseria are N. gonorrhoeae (the gonococcus or Gc), the sole causative agent of gonorrhea, and Neisseria meningitidis (the meningococcus or Mc), the major cause of bacterial meningitis in teenagers and young adults. While these organisms are true pathogens that have the ability to cause disease in otherwise healthy people, they represent pathogens that have evolved from and share many of the colonization determinants with the commensal Neisseria and can behave either as nonpathogenic (commensal or asymptomatic) or pathogenic organisms when colonizing different individuals.
N. gonorrhoeae was the first member of the genus described and is a unique member of the genus since it mainly colonizes the human genital tract, and not the nasopharynx or oral cavity. A disease similar to gonorrhea has been described throughout human history (119) . Gonorrhea is still prevalent worldwide today, and the rise in antibiotic resistance makes gonorrhea a major public health concern (120). Gonococcal infection usually results in symptomatic disease in men, with an obvious purulent exudate and painful urination; it is more linked to asymptomatic infections in women, with a less obvious exudate and little or no pain during uncomplicated infection (121, 122) . However, there are no general population studies that measure the frequency of asymptomatic infection in either gender. In the developed world, a significant portion of infections are found within populations of men who have sex with men (123) . Of the human-adapted Neisseria, Gc more often elicits inflammation than the other species. While the reasons for this are unknown, it is a reasonable hypothesis that inflammation increases sexual transmission.
N. meningitidis, like the commensal Neisseria, colonizes the nasopharynx and usually behaves similarly to the commensal Neisseria (124) . However, in a small number of colonized people (<1%) the meningococcus can leave the nasopharynx and become systemic to cause meningococcemia or bacterial meningitis (125) . Localized outbreaks of meningococcal disease occur when young adults from different geographical regions come in close contact with one another (e.g., dormitories or military barracks) or during the dry season in sub-Saharan Africa (126) . These epidemiological correlations suggest that there are both immunological and environmental factors that can contribute to meningococcal disease. However, since many outbreaks are clonal in nature, it is postulated that there are hyper-invasive Mc clones that are more able to become systemic and/or cross the blood-brain barrier (124) . While many genes or gene products have been correlated with hyperinvasive lineages, there is no single virulence factor that correlates with systemic disease (127) (128) (129) (130) . Although the frequency of invasive disease is low relative to commensal carriage, the high level of mortality associated with Mc meningitis makes this the most dangerous member of the genus.
Gc and Mc appear to have evolved from a common progenitor since they show greater than 90% identity in their core genomic sequences and are closely related (131) . Not surprisingly, due to their different sites of colonization, transmission, and pathogenesis, each species has unique defining genetic determinants (e.g., the capsule of Mc), but the genetic similarities between these species are more impressive than their differences (132) . One genetic characteristic that differentiates the pathogenic from the commensal Neisseria is the greater amount of phenotypic variation that is found in the pathogenic species. For reasons that are not well understood, the commensal Neisseria have low potential for variation; Mc has extensive variation but does not have the vast capacity that Gc encodes. One plausible hypothesis is that both Gc and Mc use variation for functional reasons not needed by the commensal Neisseria, while as an STI, Gc requires a greater amount of variation for immune evasion.
Phase and Antigenic Variation in the Neisseria
The pathogenic Neisseria are notable in the number of genes that can undergo stochastic variation of gene expression. The types of stochastic variation that have been described in the pathogenic Neisseria include on/off phase variation, which is the reversible expression or nonexpression of gene products, and antigenic variation, the expression of multiple antigenic forms of a gene product or structure. There are three major surface structures that all can undergo both phase and antigenic variation: the lipooligosaccharide (LOS) glycan structure that constitutes the outer layer of the outer membrane (133) , the family of outer membrane adhesins called opacity proteins (134) , and the type IV pilus (135) . The properties and mechanism of variation of each of these important antigenically variable surface structures will be discussed in detail below.
There are also 50 to 100 genes in each pathogenic Neisseria strain that undergo simple on/off phase variation (136) . Many of the phase-variable genes are involved in pathogenesis, but other functions are controlled by phase variation, and not all of the gene products have a known function. The phase-variable genes mostly alter expression through changes in polynucleotide repeats (PNR) located either in the promoter of the gene or within the coding sequence (Fig. 9 ). The number of nucleotides within the PNR can change ±1 during DNA replication through a process called slipped-strand mispairing (137) . If the PNR is located within the promoter region of a gene, the size of the PNR therefore sets whether the -10 and -35 elements of the promoter are within an optimal distance of one another (high expression), a suboptimal distance (moderate expression), or a nonfunctional distance (no expression) ( Fig. 9A ). If the PNR is within a coding region, the change in repeat number can alter the translational reading frame and allows expression of the full-length gene product, or with a frame-shift that alters the reading frame this usually results in a premature stop codon (Fig. 9B ). This large number of phase-variable genes with pathogenic Neisseria creates a situation where every population is a heterogeneous mix of phenotypic variants. This is one reason why genetic complementation is so critical in laboratory studies using mutants.
LOS Variation
As Gram-negative bacteria, members of the Neisseria genus have two phospholipid bilayer membranes. The outer membrane is an asymmetric bilayer, with the outer leaflet being comprised of LOS molecules. LOS is similar to the lipopolysaccharide expressed by many Gram-negative bacteria but does not have the long extended O-antigen polymeric sugars characteristic of lipopolysaccharide (133) . The LOS has many functions for Neisseria including the barrier function of the outer membrane, immuno-stimulatory endotoxin activity, and providing complex glycosylation substrates that are recognized as being similar to host glycans and binding host lectins (138) . LOS is a major component of the outer membrane vesicles that are the basis of experimental vaccines (139) and an important immune-stimulatory component of the new Mc group B vaccine Bexsero (140) .
In the pathogenic Neisseria, there are several invariant glycosyltransferases that help build the LOS glycan structure and a few phase-variable glycosyltransferases that each can be on or off in different cells (141) (142) (143) . The glycan structure of the LOS is defined by the combination of the phase-variable glycosyltransferases that produce each enzyme. Phase variation of the LOS biosynthetic glycosyltransferase is mediated by changes in PNRs (polyG) found within the coding region of each variable gene, allowing for a simple on/off alteration in expression of the protein. The effect of these variable expression genes on the bacteria surface is amplified by the further modification of some but not all glycan structures by sialylation (141, 142, 144, 145) (Fig. 10A) . LOS variation is a powerful way to use replication error to create multiple sugar structures to vary the bacterial surface. The reasons why Mc retains LOS variation despite having a distinct polysaccharide capsule covering the outer surface is not well-established, but the existence of acapsular strains and the ability of outer membrane proteins to engage host cell receptors suggests that the capsule is not a complete barrier to the bacterial surface (146) .
Opa Variation
The pathogenic Neisseria can express a family of outer membrane proteins called opacity (Opa) proteins because some of these proteins cause change in colony opacity when cells are grown on agar plates (134, 147) . Mc encodes 4 to 5 variable opa loci, Gc encodes 11 to 13 opa loci, and commensal Neisseria encode 1 to 2 opa loci. Opa proteins are beta-barrel outer membrane proteins that mainly act as adhesins. Different Opa variants bind to different members of the human carcinoembryonic antigen-related cell adhesion molecules (CEACAM) receptor family or to heparin sulphate (148) (149) (150) . It is possible that Opa protein variation is driven more by receptor specificity than by immune selection, but this has never been directly tested.
Each opa locus is independently transcribed, and each locus is under independent phase variation control. There is a pentamer nucleotide repeat (CTCTT) contained within the DNA segment that encodes the protein secretion signal sequence (134, 151) . During DNA replication, this pentamer repeat adds or removes one repeat and puts the mature Opa protein coding sequence in or out of the reading frame of the initiating AUG (Fig. 10B ). Therefore, each Neisseria cell can have any combination of Opa proteins expressed in a stochastic manner. The frequency of Opa phase variation is influenced by promoter strength, and the rate is larger when the repeat length is longer (152, 153) .
Pilin Variation
Both the pathogenic and commensal Neisseria express a type IV pilus. The type IV pilus is an important colonization factor that also plays many roles in the (ii) Phase-ON: when the pentamer repeat number encodes an in-frame protein, the full protein is translated and the signal sequence is cleaved during secretion. (iii) Phase-OFF: when the pentamer repeat number changes to be out of frame and an altered protein coding sequence is produced (blue), leading to a premature stop codon. pathogenesis of disease. Pili help mediate adherence to host cells and tissues (154) , twitching motility (155) , resistance to polymorphonuclear leukocyte killing mechanisms (156), and genetic transfer (157) . Only the pathogenic Neisseria have the ability to antigenically vary the pilus, with all Gc strains and most Mc strains having the ability; however, a small subset of Mc strains express a nonvariable pilus that is more similar to the commensal type IV pilus but still can cause invasive disease (158).
In the pathogenic Neisseria, pilus expression and antigenicity is modulated by many different mechanisms. There is transcriptional regulation of pilus expression in Mc (159) , and if there is transcriptional regulation of pilus expression in Gc, it is by unknown mechanisms. There is stochastic phase variation of pilus expression that can result in three major levels of expression. Most clinical isolates of Gc are piliated, expressing many pili per cell (160, 161) . Since Mc do not express the pilus-dependent colony morphology characteristic of Gc, it is less certain whether Mc piliation is also strongly selected for in vivo. It is likely that loss of full piliation occurs in both Gc and Mc infections, but this has not been extensively studied. Loss of piliation would allow individual bacterial cells to escape from bacterial communities (either microcolonies or biofilms) to move to different anatomical sites or to different hosts.
Both Gc and Mc can lose a majority of pilus expression through phase variation of the pilus-associated pilC genes (162) . Both species have two independent pilC loci that each have a PNR in their coding sequences that allow them to vary on and off. Expression of either the pilC1 or pilC2 locus allows for full piliation (162) , although in Mc there have been different reported phenotypes for the PilC1 and PilC2 pili, but this has been disputed (163) . However, even when both pilC genes are phased off, there remains a low level of pilus expression, and pilus expression can be restored by inactivating the PilT traffic ATPase (164, 165) . Low piliation variants can also result from pilin antigenic variation reactions that result in a full-length pilin protein, but one that is either inefficiently assembled into pili or cannot maintain an extended pilus conformation (166, 167) . True off phase variation of pilus expression is only achieved when Gc incorporates a silent copy sequence encoding a nonsense codon (89, 166, 168) , but not all Gc isolates have silent copies with stop codons, and silent copyencoded stop codons have not been reported for Mc. Therefore, all of Mc pilus phase variation and a majority of Gc phase variation occurs between full piliation and poor piliation and not between on and off.
Most of the work on the mechanisms of pilin antigenic variation has been done using Gc, and while the central mechanisms are likely to be shared between Gc and Mc, this section will exclusively feature results from Gc, and the relationship to Mc is assumed but has not always been tested. Both Gc strains MS11 and FA1090 have been used to study pilin antigenic variation and have 15 and 19 silent copies, respectively, arranged in different loci both upstream and downstream of the expression locus (169, 170) . The silent copies differ from the expression locus in that the silent copies are missing the conserved N-terminal coding sequences, the ribosome binding site, and the transcriptional promoter ( Fig. 11A) . Thus, although the silent copies do not produce a functional protein, they supply variant sequences to pilE. Transcription of the pilE gene is not required for pilin antigenic variation, disproving the hypothesis that transcription could differentiate the donor silent copies from the recipient pilE locus (171) .
Pilin antigenic variation results from the nonreciprocal transfer of variant pilin coding sequences from one of the silent copies to the pilE locus (Fig. 11B) ; thus, the silent copies do not normally change during pilin antigenic variation. However, this may not be true for the silent copies that are located immediately upstream of the pilE gene (H.S. Seifert, unpublished observations). The segment of DNA that is transferred can be any part of the silent copy that aligns with the pilE sequence (168, 172) , and the changes can be as small as one nucleotide or the replacement of the entire sequence by the donor pilS copy sequence (168, 172) . Many pilE variants have sequence information from two silent donors, and some have three or more. The transferred sequence is always bordered by regions of micro homology that can be as small as 3 bp (168, 172) . The frequency of variants can be from 3 to 15% depending on the species and strain, and not all silent copies recombine at the same frequency (168, 173, 174) . However, the rules that govern the frequency of each donor silent copy used have not been determined. The multiple donor silent copies located at positions on either side of the recipient pilE gene create an issue for modeling how gene conversion can occur within a bacterial chromosome. This led to the hypothesis that recombination might occur between sister chromosomes, and it was found that both Gc and Mc have two chromosomal copies, while the most closely related commensal that does not undergo pilin antigenic variation (Neisseria lactamica) has one chromosomal copy (175, 176) . These pathogenic Neisseria are still genetically haploid since Gc cannot maintain different alleles at the same locus (176) .
Pilin antigenic variation relies on the general recombination and repair systems common to most bacterial species. The process is absolutely dependent on having functional RecA, RecO, and RecR recombinases and shows reduced frequencies when RecQ, RecJ, Rep, RecX, RdgC, RuvABC, or RecG are inactivated by mutation (89, (177) (178) (179) (180) (181) (182) . The partial phenotypes of some of these factors may be due to redundancy (e.g., the helicases RecQ and Rep), an enhancing role on another factor (e.g., RecX on RecA), or the processing of different substrates that can lead to antigenic variation (not known). In addition, the Holliday junction-processing helicases RuvAB and RecG are both individually required for pilin antigenic variation, but a double mutant with recG and any one of the ruvABC genes produces synthetic lethality only when pilin antigenic variation can occur (183) . Thus, cells that do not initiate pilin antigenic variation can survive, as do cells that have deleted the pilE locus (183) . Inactivation of many of the recombinases required for pilin antigenic variation can also prevent the synthetic lethality (183; H.S. Seifert, unpublished data). Inactivation of mismatch correction increases the frequency of pilin antigenic variation (and also PilC phase variation) (184) , and loss of mismatch FIGURE 11 Neisseria pilin antigenic variation. (A) The pilin loci. (i) The pilin expression locus (pilE) has a promoter sequence to initiate transcription; a seven-amino-acid signal sequence (SS, green), an absolutely conserved, N-terminal constant coding sequence (N-term, purple), and a variable carboxy-terminal coding sequence (C-term, red). The G4forming sequence is represented by the blue star, and the sRNA transcript is represented by the thin arrow. (ii) A variant pilS gene copy that has variant pilin C-terminal coding sequences (C-term, orange) but cannot express a protein product. This pilS copy has a frame shift in the 5′-coding sequences (X). Each pilS locus can have one to six repeated pilS copies (N = 1 to 6). (B) Pilin variation. Nonreciprocal transfer of variant pilS copy sequences into the pilE locus produces pilin variants. The pilS sequences that are transferred can be from any part of the pilS copy that overlaps with the pilE sequence as long as there are regions of microhomology at the ends of the transferred sequence (not shown). Some (but not all) pilS copies encode a frame shift in their 5′ potential coding sequences that can result in an altered reading frame (blue), a premature stop codon, and a nonpiliated variant. (C) The G4-forming sequence and promoter for the cis-acting sRNA. The sequence shown is on the bottom strand of the cartoons in parts A and B. The sRNA promoter is indicated by the boxed -10 and -35 sequences. The sRNA required for pilin antigenic variation initiates (+1 sRNA) within the second set of guanines in the G4 forming sequence. correction also increases the level of synthetic lethality (192) .
Several sequences are required for pilin antigenic variation. The first identified was called the Sma/Cla repeat since it often has sites for the Sma I and Cla I restriction endonucleases (185) . This repeat is present at the 3′ end of all pilin loci, both pilE and each pilS locus, regardless of the number of pilS copies in that locus. It has been suggested that the Sma/Cla repeat binds an unknown recombinase (186) , but it is likely that the Sma/Cla sequence provides an extended region of 3′homology for recombination during pilin antigenic variation. The second site that has been suggested to be important for pilin antigenic variation is the cys2 sequence within the pilE and pilS copies. This sequence encodes an invariant 10-amino-acid segment of the pilin protein that contains one of the two conserved cysteines. If the ∼30-bp conserved cys2 region is interrupted with an antibiotic resistance cassette or a 10-bp linker, normal pilin antigenic variation is disrupted, even though the same 10-bp linker inserted into the neighboring hypervariable loop sequences has no effect on the reactions (187) . It has not been determined whether the cys2 sequence is important to provide a stretch of homology during recombination or plays a more active role in the process.
The most important cis-acting sequence that has been described is the pilE-associated G4-forming sequence (93). The existence of this element was suggested by transposon insertions that totally inactivated pilin antigenic variation (171, 182) . These transposons were located upstream of the pilE gene, were not within an open reading frame, and did not alter pilin expression (171, 182) . Saturation mutagenesis of the region containing the transposon insertions showed that single point mutations in any one of 12 G-C bps disrupt pilin antigenic variation (93) (Fig. 11) . Mutation of the four T-A bp within the region of G-C bp or sequences immediately adjacent to this GC-rich segment had no effect on pilin antigenic variation (93). The G-rich strand was predicted to form a G4 structure, and this prediction was confirmed by a series of in vitro assays (93). The structure of this G4 determined by nuclear magnetic resonance spectroscopy predicted that the G4 structure could bind to RecA, and this was confirmed experimentally (94) . Interestingly, other G4-forming sequences precisely replacing the pilE G4 sequence could not mediate pilin antigenic variation and did not bind RecA (93, 94). Whether RecA binding to the pilE G4 structure is important for pilin antigenic variation has not been determined.
Activity of the G4-forming sequence was also found to depend on a promoter element that was located between the G4-forming sequence and the pilE that transcribes the G-rich strand the opposite direction from the pilE gene (188) . The transcript produced initiates within the second set of guanines within the G4-forming sequence, but this transcript is of low abundance and does not appear to have a defined 3′-end (188) . It is likely that this transcript allows the G4 structure to form by melting the DNA duplex and occluding the C-rich strand through the formation of an R-loop. What molecular steps follow these reactions are not known. Expression of the G4 structure and transcript at an ectopic locus does not rescue a promoter mutation, showing that this element must be present in cis (188) . Moreover, the G4-forming sequence and associated transcript only work in the normal orientation at the normal location in the chromosome. If the direction is reversed or the G-rich and C-rich strand are exchanged, antigenic variation cannot proceed (188) . One hypothesis that might explain the orientation is that the G4 structure is on the lagging strand, while the putative R-loop is on the leading strand and that these elements act by specifically interacting with the replication apparatus. A replicationinterrupting structure may be a common mechanism of initiating recombination-based diversity generation since other G-rich sequences have been subsequently proposed to have roles in Borrelia (92) and Treponema pallidum antigenic variation (189). When replication stalls at the G-rich site, a programmed recombination/ repair process occurs to initiate each phenotypic variation process.
Knowledge Gaps
The three major variation systems expressed by the pathogenic Neisseria species strongly suggest that they are under strong selection for stochastically produced subpopulations. While we assume that this selection is immune-based, it is almost certain that the initial evolution of these diversity-generating systems was based on functional alterations (e.g., different Opa receptors) and not immune selection. Like many issues in biology, these diversity-generation systems are used for more than one function. Regardless of whether it is functional, immune selection, or both, the existence and conservation of these systems also suggest that the pathogenic Neisseria function as populations to allow subpopulations to be selected for rather than regulation that effects the entire population.
What is most notable about Neisseria antigenic variation is that these are mostly mucosal pathogens, while many of the other antigenically variable organisms are blood-borne and regularly exposed to antibody and phagocyte surveillance. It is possible that the ability to continually infect the high-risk, core group of the sexually active population is the driving selective force behind Gc variation. However, there are reports that Gc infection is immune-suppressive (190) , which begs the question of why such a large amount of antigenic variation is necessary. The case for immune selection is less obvious for Mc, with its largely commensal lifestyle and smaller capacity for variation. With Mc it may be functional selection that remains the driving force for phenotypic variation, and whether phenotypic variation contributes to invasive disease remains unanswered.
While there have been many advances into understanding the mechanisms behind the gene conversion reactions that underlie pilin antigenic variation, there are many open questions remaining. Are the mechanisms used by Mc identical to those used by Gc? Does recombination occur between diploid chromosomes? Does the G4 sRNA play a direct role in the process? Is there a factor that facilitates G4 structure formation? Does G4 structure formation promote recombination through inhibiting replication, binding a recombinase, or both? What other sites are required to complete this highfrequency, gene conversion process? Is this a homologous recombination process using heteroduplex, an annealing process, or both? Answering these questions will increase our understanding of the possible mechanisms that allow all of the phenotypic variation in prokaryotes and eukaryotes that rely on recombination.
